These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A molecular approach to breast imaging. Fowler AM J Nucl Med; 2014 Feb; 55(2):177-80. PubMed ID: 24434288 [TBL] [Abstract][Full Text] [Related]
3. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma. Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622 [TBL] [Abstract][Full Text] [Related]
4. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer. Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138 [TBL] [Abstract][Full Text] [Related]
6. Positron emission mammography: better than magnetic resonance mammography? Schilling K Eur J Radiol; 2012 Sep; 81 Suppl 1():S139-41. PubMed ID: 23083565 [No Abstract] [Full Text] [Related]
7. Co-registration of MR-mammography and X-ray mammography. Dietzel M; Baltzer PA; Hopp T; Ruiter NV; Kaiser WA Eur J Radiol; 2012 Sep; 81 Suppl 1():S27-9. PubMed ID: 23083591 [No Abstract] [Full Text] [Related]
8. Integrated whole-body PET/MR hybrid imaging: clinical experience. Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography/CT versus MRI in liver metastasis: is there a winner? Grassetto G; Maffione AM; Rubello D J Med Imaging Radiat Oncol; 2014 Oct; 58(5):529-31. PubMed ID: 25287485 [No Abstract] [Full Text] [Related]
10. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Schmidt GP; Kramer H; Reiser MF; Glaser C Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. Akay S; Kocaoglu M; Emer O; Battal B; Arslan N J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135 [TBL] [Abstract][Full Text] [Related]
15. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. Dirisamer A; Halpern BS; Flöry D; Wolf F; Beheshti M; Mayerhoefer ME; Langsteger W Eur J Radiol; 2010 Feb; 73(2):294-9. PubMed ID: 19181468 [TBL] [Abstract][Full Text] [Related]
16. Second-look ultrasound: only for biopsy or more? Leung JW Eur J Radiol; 2012 Sep; 81 Suppl 1():S87-9. PubMed ID: 23083617 [No Abstract] [Full Text] [Related]
17. Dedicated PET device for breast PET and MRI/PET correlations. Seiler S; Lenkinski RE Eur J Radiol; 2012 Sep; 81 Suppl 1():S149-50. PubMed ID: 23083569 [No Abstract] [Full Text] [Related]
19. Relative value of three whole-body MR approaches for PET-MR, including gadofosveset-enhanced MR, in comparison to PET-CT. Obara P; Loening A; Taviani V; Iagaru A; Hargreaves BA; Vasanawala S Clin Imaging; 2018; 48():62-68. PubMed ID: 29031209 [TBL] [Abstract][Full Text] [Related]
20. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer. Parry PV; Engh JA Neurosurgery; 2013 Dec; 73(6):N11-3. PubMed ID: 24257336 [No Abstract] [Full Text] [Related] [Next] [New Search]